Few words in menopause care cause as much confusion as bioidentical. You will hear that bioidentical hormones are safer, more natural, and personalized to your body, and you will also hear doctors and major medical bodies warn against them. Both things can sound true at once, and that is because the single word is being used for two very different things. One is a regulated, evidence-based form of hormone therapy that many women already take. The other is a custom-mixed product with far less oversight. Sorting out which is which is the key to a calm, informed conversation with your doctor.
Key Takeaway
"Bioidentical" simply means a hormone chemically identical to the ones your body makes, such as estradiol and progesterone. Regulated body-identical HRT (approved estradiol patches, gels, and micronized progesterone) is bioidentical, evidence-based, and widely prescribed. Compounded bioidentical hormone therapy is custom-mixed, not FDA-approved, and marketed as safer or more natural, claims that The Menopause Society, NICE, and the National Academies say the evidence does not support. Being bioidentical does not, by itself, make a hormone safer. This article is education, not a diagnosis.
What "Bioidentical" Actually Means
The term bioidentical describes a hormone that is molecularly identical to one your ovaries produce, most often estradiol (the main estrogen of the reproductive years) and progesterone. That is a description of chemistry, nothing more. It does not tell you where the hormone came from, whether it was tested, or how it was made.
Here is the point that gets lost. Both compounded products and many standard, approved prescriptions are bioidentical. An estradiol patch from a pharmacy and micronized progesterone in a capsule are bioidentical hormones, and they are the ones your doctor is most likely to reach for. So the real question is never simply "bioidentical or not." It is whether a bioidentical hormone comes in a regulated, tested, approved product or in a custom compounded one.
The Two Very Different Products
Under the single umbrella word sit two categories that could hardly be more different in how they are made and overseen.
Body-identical HRT (regulated)
These are government-approved pharmaceutical products that happen to be bioidentical. Common examples are transdermal estradiol (patches, gels, and sprays) and oral micronized progesterone. They are produced in standardized, measured doses, tested for purity and consistency, and come with a full label describing benefits, risks, and side effects. In the UK, clinicians often use the term body-identical to make clear they mean these approved options, not compounded ones. This is mainstream, evidence-based menopause care.
Compounded bioidentical hormone therapy (cBHT)
These are prepared by a compounding pharmacy, which mixes hormones into a custom cream, gel, capsule, troche, or pellet, frequently in combinations or doses not found in approved products. Compounded preparations are not reviewed or approved by the FDA for safety or effectiveness. Individual batches are generally not tested the way an approved medicine is, so the actual amount of hormone you receive can vary. They are often sold with the promise of being tailored to you based on hormone testing, a promise we will come back to.
The one-line version
If a product is bioidentical and approved by a regulator, it is what most doctors call body-identical HRT, and it is a standard option. If it is bioidentical but custom-mixed by a compounding pharmacy and sold as "personalized," it is compounded (cBHT), and that is the category major bodies advise caution about.
Body-Identical vs Compounded: Side by Side
The molecule can be the same in both columns. What differs is everything around the molecule: testing, dosing, labeling, and oversight.
| Feature | Body-identical HRT (regulated) | Compounded bioidentical (cBHT) |
|---|---|---|
| Chemically bioidentical | Yes (e.g. estradiol, micronized progesterone) | Yes, same molecules |
| Regulatory approval | Approved by FDA / MHRA and equivalents | Not FDA-approved for safety or effectiveness |
| Dose consistency | Standardized, measured, reproducible | Can vary between batches and pharmacies |
| Purity and sterility testing | Required and routine | Not routinely tested batch by batch |
| Safety label and warnings | Full approved label provided | Often lacks standardized risk information |
| Evidence base | Studied in clinical trials | Limited high-quality safety and efficacy data |
| Guideline stance | Recommended as standard care | Not recommended for routine use |
The "Safer" and "Natural" Claims
The strongest selling points for compounded products are that they are more natural and therefore safer. Both claims deserve a closer look.
"Natural" is a marketing word here, not a scientific one. Both compounded and approved bioidentical hormones are typically made in a laboratory, often starting from plant compounds in soy or yam, then converted into a hormone identical to what the body makes. A compounded cream is not closer to nature than an approved patch. The two can contain the very same estradiol molecule.
"Safer" is not supported by evidence. Because a compounded product is custom-mixed rather than approved and tested, its safety is actually harder to be sure of, not easier. In 2020 the National Academies of Sciences, Engineering, and Medicine reviewed the field and found a lack of high-quality data on the safety and effectiveness of compounded preparations, concluded that their widespread use is not supported by the evidence, and recommended restricting their use to specific situations. Importantly, any estrogen therapy carries the same general considerations whether it is compounded or approved, so a "bioidentical" label does not remove risk. Marketing that implies compounded hormones are risk-free can give a false sense of security.
What The Menopause Society and NICE Say
Leading menopause authorities land in a consistent place: regulated body-identical hormones are part of standard care, and custom compounded products are cautioned against for routine use.
The Menopause Society (formerly NAMS), in its 2022 Hormone Therapy Position Statement, lists specific concerns with compounded bioidentical hormone therapy, including minimal government regulation and monitoring, the risk of overdosing or underdosing, possible impurities or lack of sterility, a lack of scientific efficacy and safety data, and the absence of a label outlining risks. It does not recommend cBHT for routine use, while supporting approved hormone therapy where appropriate.
In the United Kingdom, NICE guidance on menopause advises that there is limited evidence on the safety and effectiveness of compounded bioidentical hormones and does not recommend them, and it distinguishes these from the regulated, body-identical options that are widely prescribed. The American College of Obstetricians and Gynecologists reaches a similar conclusion, favoring approved products and reserving compounded therapy for narrow, specific circumstances.
The consensus is not "bioidentical hormones are bad." It is that a hormone should come in a regulated, tested product, and that being labeled bioidentical or natural is not a substitute for that oversight.
Saliva Testing and "Personalized" Doses
A common part of the compounded pitch is a saliva or blood test that promises to reveal your exact hormone levels so a formula can be tailored to you. It sounds precise and appealing. The trouble is that in perimenopause, hormone levels swing dramatically from hour to hour and day to day, so a single snapshot rarely reflects your overall picture.
For this reason, The Menopause Society and other bodies advise against using saliva testing to guide tailored hormone doses. The results are not reliable enough, and doses adjusted to hit a target level are not validated by evidence. In everyday practice, hormone therapy decisions are usually guided by your symptoms and personal history rather than by chasing a number, which is something your doctor can review with you.
When Compounded May Be Appropriate
Cautioned against for routine use does not mean never. Guidelines recognize a few specific situations where a compounded preparation can be reasonable, always under medical supervision:
- A genuine allergy or intolerance to an ingredient (such as a dye, peanut oil, or other excipient) in every approved product.
- A need for a dose or formulation that simply is not available in any approved product.
- Other individual clinical circumstances where an approved option is not suitable, as judged by your clinician.
In those cases, the decision is made with a doctor who knows your history, not on the basis of "natural is better." For the large majority of women, an approved body-identical option can meet the same need with more predictable dosing and a clearer safety profile.
How to Talk to Your Doctor
You do not need to memorize the science to have a good conversation. You mainly need to know the right questions, so you can tell a marketing promise from a medical recommendation. It helps to walk in with a clear picture of your own symptoms and what you are hoping to improve.
Questions worth asking
- "Is there an approved, body-identical option that would suit me, rather than a compounded one?"
- "If a compounded product is being suggested, why is an approved product not appropriate for me specifically?"
- "What does the evidence say about the safety and effectiveness of what you are recommending?"
- "Do I actually need hormone testing to make this decision, or will we go by my symptoms and history?"
- "What are the benefits and risks for someone with my personal and family history?"
If a provider leans heavily on words like natural, personalized, or completely safe, that is a reasonable moment to ask for the evidence, or to seek a second opinion from a menopause-informed clinician. You are allowed to ask until the answer makes sense to you. For a fuller guide, see how to talk to your doctor about perimenopause.
Seeing Your Pattern with Peritale
The strongest thing you can bring to any hormone conversation is a clear, honest picture of what your body is actually doing over time, not a single lab value and not a vague sense that something is off. That clarity is exactly what makes these decisions easier to think through with your doctor.
Peritale gives you an objective, comprehensive picture of how the hormonal transition is affecting you, with no blood tests and nothing invasive at home. Using AI and a simple seven-minute process on a standard smartphone, it maps the effects on your cognitive performance (reaction speed, word retrieval, attention), your hearing and vision, and dozens of markers that computer vision reads across your skin, hair, and eyes, all alongside comprehensive symptom mapping. You get a complete snapshot that becomes your baseline, so you can talk to your doctor about what is really bothering you, take charge of your care, and start to feel like yourself again. Your first check is free.
You are not imagining it
In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.
Start My Free CheckThe Bottom Line
Bioidentical is a chemistry word that got tangled up in marketing. Regulated body-identical HRT, such as estradiol and micronized progesterone, is bioidentical, evidence-based, and a standard option many women use. Custom compounded bioidentical hormone therapy is the same molecules without the same testing and approval, and the claims that it is safer or more natural are not supported by The Menopause Society, NICE, or the National Academies. For most women, an approved option can do what a compounded one promises, with more predictable dosing. Knowing the difference lets you ask better questions and make a choice that fits you. This is education for awareness, not a diagnosis.
This content is for educational purposes only. Peritale is a general wellness product, not a medical device. It is not intended to diagnose, treat, cure, or prevent any disease. It does not test or measure hormones. Always consult a qualified healthcare provider for medical advice, including any decision about hormone therapy.
References and Further Reading
- The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. PubMed
- National Institute for Health and Care Excellence (NICE). Menopause: identification and management (NG23). nice.org.uk/guidance/ng23
- National Academies of Sciences, Engineering, and Medicine. The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use. Washington, DC: The National Academies Press; 2020. nap.nationalacademies.org/catalog/25791
- American College of Obstetricians and Gynecologists. Compounded Bioidentical Menopausal Hormone Therapy. Clinical Consensus. acog.org
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. fda.gov
Citations are provided so you can read the primary sources yourself. This list is a starting point, not a complete review, and does not constitute medical advice.